APAC Craniomaxillofacial Implants Market

APAC Craniomaxillofacial Implants Market Size (2023 To 2028)

The craniomaxillofacial implants market size in APAC was valued at USD 0.36 billion in 2023. This value is further predicted to be worth USD 0.52 billion by 2028, growing at a CAGR of 7.92% from 2023 to 2028.

In recent years, the growing attention to aesthetics and high beauty awareness among young consumers is driving the demand for craniomaxillofacial implants (CMF). From now on, advancements in implant technologies and the growing preference for minimally invasive techniques, especially in trauma cases, are expected to drive this market for years. In addition, the growing number of people suffering from craniomaxillofacial injuries caused by traffic accidents, domestic accidents, occupational trauma, violence, sports, etc., will stimulate the market growth rate. One of the leading causes of head and neck trauma is a traffic accident. According to recent statistics from the World Health Organization, approximately 1.5 million people die yearly from traffic accidents.

Most of these accidents result in severe traumatic facial and skull injury, requiring reconstructive procedures with craniomaxillofacial implants. Non-fatal traffic accidents are also one of the main problems which lead to hospitalizations and even permanent disabilities in the majority population each year. Moreover, untapped opportunities, positive economic development, and improved healthcare infrastructure will likely boost the market further.

Reconstructive surgery involves implants, bone grafts, and growth factors primarily required for successful reconstructive plastic surgeries. Reconstructive surgeries are done for hereditary or developed craniomaxillofacial abnormalities due to congenital disabilities, tumor resection, infections, or aesthetic reasons. Bio-compatible implants are typically used for craniofacial skeletal reconstruction to correct bony defects and hold other bones in position. The growth of the APAC craniomaxillofacial Implants market is projected to focus on plastic surgeries for sales revenues for the next six years. The increase in this APAC region can be attributed to the growing number of traffic accident cases and resulting injuries and newborns with facial deformities, which will further stimulate the growth of this market.

The high costs of these reconstructive surgeries with expensive implants and the lack of skilled professionals will hamper the market growth rate. In addition, successful plastic procedures require highly trained doctors, which may cause restraint for many underdeveloped nations.

This research report on the APAC craniomaxillofacial implants market has been segmented and sub-segmented into the following categories.

By Type:

• Mid Face
• Plates
• Screws
• Mandibular Orthognathic Implants
• Neuro
• Mesh
• Bone Graft
• Dural Repair

The midface segment is anticipated to capture the leading share of the APAC craniomaxillofacial implants market during the forecast period.

By Material of Construction:

• Titanium
• Polymer

The polymer segment had the leading share of the APAC market in 2022 and the same trend is expected to continue during the forecast period.

By Application:

• Internal Fixators
• External Fixators

The external fixators segment held the major share of the APAC market in 2022.

By Property:

• Non-Absorbable Fixators
• Re-absorbable Fixators

By Country:

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

Geographically, the APAC regional market is anticipated to hold a considerable share of the worldwide market by the end of the forecast period.

The China craniomaxillofacial Implants market was the most dominating regional market in APAC and accounted for the largest revenue share of over 40% in 2022. The growth of the Chinese market can be attributed to the availability of technologically advanced implants, increased awareness programs and conferences, and the increased volume of CMF procedures. In addition, the region will expand further due to the growing awareness of deformity correction surgeries and the presence of established healthcare facilities.

Among the countries of the APAC region, the South Korean craniomaxillofacial Implants market is projected to experience a healthy CAGR during the forecast period, owing to the increase in the health expenditure of the population and the increase in the rate of sports-related injuries. Moreover, improvement in healthcare infrastructure and healthcare-related plans and the availability of new opportunities for market expansion is likely to boost the regional craniomaxillofacial Implants market. For example, according to the NCBI, a study reported that about 2,325 people said broken noses and facial bones were caused by accidents and sports injuries in Seoul, South Korea, between 2022 and 2028.

The Japanese craniomaxillofacial Implants market is projected to exhibit a high CAGR during the forecast period. It holds a substantial share of the APAC market during the forecast period owing to the growing number of traumatic craniofacial surgeries, increasing disposable income, increased concentration of market players, and the growing number of reconstructive surgeries. Japan has the best healthcare providers globally, with the best facilities and healthcare professionals to take up craniomaxillofacial surgeries.

KEY MARKET PLAYERS

Companies playing a noteworthy role in the APAC craniomaxillofacial implants market profiled in the report are Stryker, KLS Martin, Depuy Synthes, Zimmer Biomet, Medtronic, Integra Lifesciences, OsteoMed, Medartis AG, Matrix Surgical, and Calavera.